Symmetrical polyarthritis. Time for treatment targets in rheumatoid arthritis. by Emery, P, Buch, M, Ostör, A, Kirkham, B, Taylor, P, Estrach, C, Jenkinson, T, McInnes, I, Porter, D

Contemporary treatment principles for early rheumatoid arthritis: a consensus statement. by Kiely, P, Brown, A, Edwards, C, O'Reilly, D, Ostör, A, Quinn, M, Taggart, A, Taylor, P, Wakefield, R, Conaghan, P

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies by Baraliakos, X, Ranza, R, Östör, A, Ciccia, F, Coates, LC, Rednic, S, Walsh, JA, Douglas, K, Gao, T, Kato, K, Song, I-H, Ganz, F, Deodhar, A

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy (vol 49, pg 1197, 2010) by Deighton, C, Hyrich, K, Ding, T, Ledingham, J, Lunt, M, Luqmani, R, Kiely, P, Bukhari, M, Abernethy, R, Ostor, A, Bosworth, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis. by Bukhari, M, Abernethy, R, Deighton, C, Ding, T, Hyrich, K, Lunt, M, Luqmani, R, Kiely, P, Bosworth, A, Ledingham, J, Ostör, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy. by Deighton, C, Hyrich, K, Ding, T, Ledingham, J, Lunt, M, Luqmani, R, Kiely, P, Bukhari, M, Abernethy, R, Ostor, A, Bosworth, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy. by Deighton, C, Hyrich, K, Ding, T, Ledingham, J, Lunt, M, Luqmani, R, Kiely, P, Bukhari, M, Abernethy, R, Ostor, A, Bosworth, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. by Ding, T, Ledingham, J, Luqmani, R, Westlake, S, Hyrich, K, Lunt, M, Kiely, P, Bukhari, M, Abernethy, R, Bosworth, A, Ostor, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J, Deighton, C

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial... by Al-Laith, M, Jasenecova, M, Abraham, S, Bosworth, A, Bruce, I, Buckley, C, Ciurtin, C, D'Agostino, M, Emery, P, Gaston, H, Isaacs, J, Filer, A, Fisher, B, Huizinga, T, Ho, P, Jacklin, C, Lempp, H, McInnes, I, Pratt, A, Östor, A, Raza, K, Taylor, P, Van Schaardenburg, D, Shivapatham, D, Wright, A, Vasconcelos, J, Kelly, J, Murphy, C, Prevost, A, Cope, A